Skip to main content

Table 3 NPRS ‘average pain’ scores at baseline and Weeks 2 and 8 (FAS)

From: Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study

NPRS ‘average pain’ scores

PHN

(n = 89)

HIV-AN

(n = 5)

NBP

(n = 50)

CRNP

(n = 22)

PONP

(n = 198)

Other

(n = 56)

Overall

(n = 420)

First treatment

 Baseline, mean (95% CI)

7.1 (6.9, 7.5)

n = 88

6.4 (5.1, 7.7)

n = 5

7.3 (6.8, 7.9)

n = 50

7.2 (6.6, 7.8)

n = 22

6.8 (6.6, 7.1)

n = 198

6.9 (6.4, 7.4)

n = 56

6.9 (6.7, 7.1)

n = 419

 Weeks 2 and 8, mean (95% CI)

4.9 (4.4, 5.4)

n = 89

4.6 (2.0, 7.3)

n = 4

4.8 (4.2, 5.5)

n = 48

5.8 (4.9, 6.7)

n = 21

5.2 (4.9, 5.5)

n = 195

4.5 (4.0, 5.1)

n = 56

5.0 (4.8, 5.2)

n = 412

 Percentage reduction, mean (95% CI)

29.7 (23.4, 36.0)

34.5 (7.6, 61.5)

30.9 (21.7, 40.1)

21.0 (11.6, 30.5)

22.3 (17.7, 27.0)

34.3 (27.3, 41.4)

26.6 (23.6, 29.6)

Second treatment

 Baseline, mean (95% CI)

7.1 (6.5, 7.7)

n = 39

6.5 (3.6, 9.4)

n = 2

7.7 (6.7, 8.7)

n = 15

6.9 (5.9, 7.9)

n = 8

6.8 (6.4, 7.2)

n = 97

6.6 (5.7, 7.5)

n = 19

6.9 (6.6, 7.2)

n = 180

 Weeks 2 and 12, mean (95% CI)

4.7 (4.1, 5.3)

n = 39

3 (–)

n = 2

4.3 (2.8, 5.8)

n = 12

3.4 (1.6, 5.2)

n = 6

4.9 (4.4, 5.4)

n = 85

5.1 (4.1, 6.1)

n = 18

4.8 (4.5, 5.1)

n = 162

 Percentage reduction, mean (95% CI)

30.5 (19.8, 41.2)

n = 38

51.3 (29.2, 73.4)

n = 2

44.9 (24.7, 65.1)

n = 12

51.0 (24.3, 77.7)

n = 6

25.0 (16.5, 33.5)

n = 85

21.4 (5.2, 37.6)

n = 18

28.7 (22.9, 34.5)

n = 161

Third treatment

 Baseline, mean (95% CI)

6.9 (5.9, 7.9)

n = 16

–

7.5 (4.6, 10.4)

n = 4

7.8 (6.3, 9.3)

n = 4

6.3 (5.8, 6.8)

n = 38

6.8 (5.6, 8.0)

n = 8

6.7 (6.3, 7.1)

n = 70

 Weeks 2 and 12, mean (95% CI)

3.9 (2.9, 4.9)

n = 14

–

5.5 (3.5, 7.5)

n = 4

5.0 (2.6, 7.4)

n = 4

4.4 (3.7, 5.1)

n = 29

5.2 (4.2, 6.2)

n = 8

4.5 (4.0, 5.0)

n = 59

 Percentage reduction, mean (95% CI)

42.3 (26.8, 57.8)

n = 14

–

25.4 (15.3, 35.5)

n = 4

35.5 (8.8, 62.2)

n = 4

23.1 (9.5, 36.7)

n = 29

13.6 (–20.8, 48.0)

n = 8

27.3 (18.1, 36.5)

n = 59

  1. CI, confidence interval; CRNP, cancer-related neuropathic pain; FAS, full analysis set; HIV-AN, HIV associated neuropathy; NBP, neuropathic back pain; NPRS, numeric pain rating scale; Other, other non-diabetic PNP; PHN, postherpetic neuralgia; PONP, post-operative and post-traumatic neuropathic pain